Authors
Latest:
Synchronization of Treatment With Erythropoiesis-Stimulating Agents and ChemotherapyIn outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.
Latest:
Specialty Oncology Pharmacy PracticesA SORx CCS Program is the touchstone for all other SORx operations, and for clients, it is the face of the pharmacy. An efficient, personalized CCS staffed by highly motivated, registered pharmacy technicians results in very satisfied clients.
Latest:
New Non-Hormonal Contraceptive Gel Found to Be EffectiveLactic acid, citric acid, and potassium bitartrate is a prescription combination, non-hormonal contraceptive gel found to be 86.3% effective with typical use.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Patients, Pharmacists, and Other Caregivers Beginning to Realize Potential of AIA well-executed, human-like digital relationship can transform patient engagement to patient activation.
Latest:
Promising Biomarkers Emerging Across the Spectrum of Prostate Cancer CareResearchers seek improved biomarkers to distinguish between malignant and benign disease.
Latest:
Palliative Chemo May Worsen QOL Near DeathPharmacists should reconsider recommending toxic chemotherapy for cancer palliation because it may significantly worsen terminal cancer patients' quality of life near death.
Latest:
Outcomes Associated With Primary and Secondary Nonadherence to Cholesterol MedicationsThis study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.
Latest:
Essential Health Benefits, Part 1This is the first of a 2-part series on the development of the essential health benefit package prescribed under the Patient Protection and Affordable C are Act.
Latest:
Advocating for Patients with Diabetic NephropathyAlthough no cure exists, pharmacologic and nonpharmacologic measures can help patients prevent onset or progression of diabetic nephropathy to preserve kidney function.
Latest:
Initiating Drug Therapy in Multiple Sclerosis Patients: Effect on Healthcare CostsMultiple sclerosis (MS) is a disease of inflammatory demyelination of axons of the central nervous system that results in episodes of transient neurologic deficits, progressing to permanent neurologic deterioration over time.1 The cause of MS remains unclear, but it is thought to involve both genetic susceptibility and environmental triggers, possibly viral, which result in self-sustaining autoimmune dysfunction.
Latest:
Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and DiabetesA value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.
Latest:
Job Market TrendsEmployers and pharmacy school students sometimes have differing perceptions of what it takes to successfully obtain a job in community pharmacy.
Latest:
Cost Outcomes of Diabetes Education in a Specialized Community PharmacyDiabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.
Latest:
Hepatitis C: Oral Direct-Acting Antivirals Are Standard of CareChronic hepatitis C virus (HCV) infection, estimated to affect up to 4 million Americans, is a leading cause of end-stage liver disease, hepatocellular carcinoma, and liver transplant.
Latest:
2017 Specialty Trend in Senior CareThe shifting landscape in specialty dispensing among pharmacies that service patients in senior care settings and long-term care facilities.
Latest:
Editor's Note: Are Intravenous Fluids Becoming a Commodity?With the widespread use of the intravenous route in many settings, safeguards are needed.
Latest:
Study Supports Recent Change in GINA GuidelinesA recent study demonstrated that budesonide-formoterol is superior to albuterol for as-needed exacerbation prevention in mild asthma.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
Job Market TrendsEmployers and pharmacy school students sometimes have differing perceptions of what it takes to successfully obtain a job in community pharmacy.
Latest:
Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile InfectionOur analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
